Filana Therapeutics, Inc. Estimated Litigation Liability
Filana Therapeutics, Inc. (FLNA) had Estimated Litigation Liability of $32.75 million as of 2025-12-31, per its 10-Q filed 2026-05-07.
Financial Statements › Balance Sheet › Liabilities
us-gaap:LitigationReserve · last filed 2026-05-07
- 2025-12-31: Estimated Litigation Liability $32.75M.
- 2025-09-30: Estimated Litigation Liability $35.25M.
- 2025-06-30: Estimated Litigation Liability $35.25M.
- 2025-03-31: Estimated Litigation Liability $3.00M.
| Period end | Estimated Litigation Liability |
|---|---|
| 2025-12-31 | $32.75M 10-Q · filed 2026-05-07 |
| 2025-09-30 | $35.25M 10-Q · filed 2025-11-12 |
| 2025-06-30 | $35.25M 10-Q · filed 2025-08-14 |
| 2025-03-31 | $3.00M 10-Q · filed 2025-05-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 |